Literature DB >> 28417271

Antimicrobial effects of Manuka honey on in vitro biofilm formation by Clostridium difficile.

M Piotrowski1, P Karpiński1, H Pituch2, A van Belkum3, P Obuch-Woszczatyński1.   

Abstract

Clostridium difficile is the cause of the nosocomial C. difficile infection (CDI). The conventional antibiotics used in CDI therapy are often unsuccessful, and recurrent infections may occur. Biofilm formation by C. difficile is associated with chronic or recurrent infections; biofilms may contribute to virulence and impaired antimicrobial efficacy. Manuka honey, derived from the Manuka tree (Leptospermum scoparium), is known to exhibit antimicrobial properties that are associated with its significant content of methylglyoxal, a natural antibiotic. The aim of the present study was to determine the antimicrobial effect of Manuka honey on clinical C. difficile strains belonging to four prominent polymerase chain reaction (PCR) ribotypes (RTs) (RT017, RT023, RT027 and RT046) and on their biofilm formation in vitro. Minimal inhibitory and bactericidal concentrations (MICs and MBCs, respectively) were determined using the broth dilution method. The biomass of the biofilm and the clearance of C. difficile biofilms by Manuka honey were determined using the crystal violet staining method. The MIC and MBC of Manuka honey for C. difficile strains were equal at 6.25% (v/v). PCR RT027 strains produced more biofilm in vitro than the other examined strains. Manuka honey effectively inhibited biofilm formation by C. difficile strains of different PCR RTs.

Entities:  

Keywords:  Clostridium Difficile; Crystal Violet; Methylglyoxal; Minimal Bactericidal Concentration; Toxic Megacolon

Mesh:

Substances:

Year:  2017        PMID: 28417271     DOI: 10.1007/s10096-017-2980-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  21 in total

1.  PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes.

Authors:  S L Stubbs; J S Brazier; G L O'Neill; B I Duerden
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

Review 2.  The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data.

Authors:  M Malone; T Bjarnsholt; A J McBain; G A James; P Stoodley; D Leaper; M Tachi; G Schultz; T Swanson; R D Wolcott
Journal:  J Wound Care       Date:  2017-01-02       Impact factor: 2.072

3.  Comparison of planktonic and biofilm-associated communities of Clostridium difficile and indigenous gut microbiota in a triple-stage chemostat gut model.

Authors:  Grace S Crowther; Caroline H Chilton; Sharie L Todhunter; Scott Nicholson; Jane Freeman; Simon D Baines; Mark H Wilcox
Journal:  J Antimicrob Chemother       Date:  2014-04-30       Impact factor: 5.790

4.  Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients.

Authors:  L V McFarland; C M Surawicz; W E Stamm
Journal:  J Infect Dis       Date:  1990-09       Impact factor: 5.226

Review 5.  Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response.

Authors:  Gayatri Vedantam; Andrew Clark; Michele Chu; Rebecca McQuade; Michael Mallozzi; V K Viswanathan
Journal:  Gut Microbes       Date:  2012-03-01

6.  Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile.

Authors:  Tanja Ðapa; Tanja Dapa; Rosanna Leuzzi; Yen K Ng; Soza T Baban; Roberto Adamo; Sarah A Kuehne; Maria Scarselli; Nigel P Minton; Davide Serruto; Meera Unnikrishnan
Journal:  J Bacteriol       Date:  2012-11-21       Impact factor: 3.490

7.  Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013.

Authors:  Hanna Pituch; Piotr Obuch-Woszczatyński; Dominika Lachowicz; Dorota Wultańska; Paweł Karpiński; Grażyna Młynarczyk; Sofie M van Dorp; Ed J Kuijper
Journal:  Euro Surveill       Date:  2015

Review 8.  Clostridium difficile infection: new developments in epidemiology and pathogenesis.

Authors:  Maja Rupnik; Mark H Wilcox; Dale N Gerding
Journal:  Nat Rev Microbiol       Date:  2009-07       Impact factor: 60.633

9.  Antibacterial effect of Manuka honey on Clostridium difficile.

Authors:  Eric N Hammond; Eric S Donkor
Journal:  BMC Res Notes       Date:  2013-05-07

10.  The efficacy of thuricin CD, tigecycline, vancomycin, teicoplanin, rifampicin and nitazoxanide, independently and in paired combinations against Clostridium difficile biofilms and planktonic cells.

Authors:  Harsh Mathur; Mary C Rea; Paul D Cotter; Colin Hill; R Paul Ross
Journal:  Gut Pathog       Date:  2016-06-02       Impact factor: 4.181

View more
  12 in total

Review 1.  Institutional protocols for the oral administration (gavage) of chemicals and microscopic microbial communities to mice: Analytical consensus.

Authors:  Alexander Rodriguez-Palacios; Mikhail V Khoretonenko; Sanja Ilic
Journal:  Exp Biol Med (Maywood)       Date:  2019-04

Review 2.  Biofilm Management in Wound Care.

Authors:  Chandan K Sen; Sashwati Roy; Shomita S Mathew-Steiner; Gayle M Gordillo
Journal:  Plast Reconstr Surg       Date:  2021-08-01       Impact factor: 5.169

3.  Mucin-Degrading Microbes Release Monosaccharides That Chemoattract Clostridioides difficile and Facilitate Colonization of the Human Intestinal Mucus Layer.

Authors:  Melinda A Engevik; Amy C Engevik; Kristen A Engevik; Jennifer M Auchtung; Alexandra L Chang-Graham; Wenly Ruan; Ruth Ann Luna; Joseph M Hyser; Jennifer K Spinler; James Versalovic
Journal:  ACS Infect Dis       Date:  2020-11-11       Impact factor: 5.084

Review 4.  Honey as a Potential Natural Antioxidant Medicine: An Insight into Its Molecular Mechanisms of Action.

Authors:  Sarfraz Ahmed; Siti Amrah Sulaiman; Atif Amin Baig; Muhammad Ibrahim; Sana Liaqat; Saira Fatima; Sadia Jabeen; Nighat Shamim; Nor Hayati Othman
Journal:  Oxid Med Cell Longev       Date:  2018-01-18       Impact factor: 6.543

Review 5.  Targeting the Bacterial Protective Armour; Challenges and Novel Strategies in the Treatment of Microbial Biofilm.

Authors:  Nor Fadhilah Kamaruzzaman; Li Peng Tan; Khairun Anisa Mat Yazid; Shamsaldeen Ibrahim Saeed; Ruhil Hayati Hamdan; Siew Shean Choong; Weng Kin Wong; Alexandru Chivu; Amanda Jane Gibson
Journal:  Materials (Basel)       Date:  2018-09-13       Impact factor: 3.623

6.  Antibacterial Activity of Bifidobacterium breve Against Clostridioides difficile.

Authors:  Jingpeng Yang; Hong Yang
Journal:  Front Cell Infect Microbiol       Date:  2019-08-07       Impact factor: 5.293

7.  Evaluation and comparison of the effect of honey, milk and combination of honey-milk on experimental induced second-degree burns of Rabit.

Authors:  Seyed Mehdi Hosseini; Reza Fekrazad; Hamid Malekzadeh; Parviz Farzadinia; Mohammadreza Hajiani
Journal:  J Family Med Prim Care       Date:  2020-02-28

Review 8.  Alimentary and Pharmaceutical Approach to Natural Antimicrobials against Clostridioides difficile Gastrointestinal Infection.

Authors:  Miguel Tortajada-Girbés; Alejandro Rivas; Manuel Hernández; Ana González; Maria A Ferrús; Maria C Pina-Pérez
Journal:  Foods       Date:  2021-05-19

9.  The effect of berberine chloride and/or its combination with vancomycin on the growth, biofilm formation, and motility of Clostridioides difficile.

Authors:  Dorota Wultańska; Michał Piotrowski; Hanna Pituch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-03-05       Impact factor: 3.267

10.  Antibacterial activity of varying UMF-graded Manuka honeys.

Authors:  Alodia Girma; Wonjae Seo; Rosemary C She
Journal:  PLoS One       Date:  2019-10-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.